vs
Side-by-side financial comparison of KINGSTONE COMPANIES, INC. (KINS) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
RHYTHM PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($57.3M vs $56.4M, roughly 1.0× KINGSTONE COMPANIES, INC.). KINGSTONE COMPANIES, INC. runs the higher net margin — 26.2% vs -83.0%, a 109.1% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 34.0%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 25.6%).
Kingstone Companies, Inc., headquartered in Kingston, New York, provides property and casualty insurance products through its subsidiary, Kingstone Insurance Company. It places contracts with the third-party licensed premium finance company through its subsidiary Payments, Inc., a NYS licensed Insurance Premium Finance Company. Kingstone Insurance Company was ranked #1 of the 81 insurers rated by the Professional Insurance Agents Association in its 2010 Company Performance Survey. The company...
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
KINS vs RYTM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $56.4M | $57.3M |
| Net Profit | $14.8M | $-47.5M |
| Gross Margin | — | 91.6% |
| Operating Margin | 32.7% | -82.2% |
| Net Margin | 26.2% | -83.0% |
| Revenue YoY | 34.0% | 36.9% |
| Net Profit YoY | 171.4% | -9.6% |
| EPS (diluted) | $1.09 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $56.4M | $57.3M | ||
| Q3 25 | $55.7M | $51.3M | ||
| Q2 25 | $52.3M | $48.5M | ||
| Q1 25 | $50.5M | $32.7M | ||
| Q4 24 | $42.1M | $41.8M | ||
| Q3 24 | $40.8M | $33.3M | ||
| Q2 24 | $36.5M | $29.1M | ||
| Q1 24 | $35.8M | $26.0M |
| Q4 25 | $14.8M | $-47.5M | ||
| Q3 25 | $10.9M | $-52.9M | ||
| Q2 25 | $11.3M | $-46.6M | ||
| Q1 25 | $3.9M | $-49.5M | ||
| Q4 24 | $5.4M | $-43.3M | ||
| Q3 24 | $7.0M | $-43.6M | ||
| Q2 24 | $4.5M | $-32.3M | ||
| Q1 24 | $1.4M | $-141.4M |
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | — | 88.5% | ||
| Q2 24 | — | 89.9% | ||
| Q1 24 | — | 89.2% |
| Q4 25 | 32.7% | -82.2% | ||
| Q3 25 | 24.6% | -102.6% | ||
| Q2 25 | 27.1% | -93.4% | ||
| Q1 25 | 9.3% | -143.7% | ||
| Q4 24 | 15.9% | -98.6% | ||
| Q3 24 | 22.3% | -132.0% | ||
| Q2 24 | 15.7% | -139.2% | ||
| Q1 24 | 5.0% | -538.7% |
| Q4 25 | 26.2% | -83.0% | ||
| Q3 25 | 19.5% | -103.1% | ||
| Q2 25 | 21.5% | -96.1% | ||
| Q1 25 | 7.7% | -151.4% | ||
| Q4 24 | 12.9% | -103.6% | ||
| Q3 24 | 17.1% | -131.2% | ||
| Q2 24 | 12.4% | -110.9% | ||
| Q1 24 | 4.0% | -544.4% |
| Q4 25 | $1.09 | $-0.73 | ||
| Q3 25 | $0.74 | $-0.82 | ||
| Q2 25 | $0.78 | $-0.75 | ||
| Q1 25 | $0.27 | $-0.81 | ||
| Q4 24 | $0.44 | $-0.71 | ||
| Q3 24 | $0.55 | $-0.73 | ||
| Q2 24 | $0.37 | $-0.55 | ||
| Q1 24 | $0.12 | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $388.9M |
| Total DebtLower is stronger | $4.4M | — |
| Stockholders' EquityBook value | $122.7M | $139.1M |
| Total Assets | $453.4M | $480.2M |
| Debt / EquityLower = less leverage | 0.04× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $388.9M | ||
| Q3 25 | — | $416.1M | ||
| Q2 25 | — | $291.0M | ||
| Q1 25 | — | $314.5M | ||
| Q4 24 | — | $320.6M | ||
| Q3 24 | — | $298.4M | ||
| Q2 24 | — | $319.1M | ||
| Q1 24 | — | $201.2M |
| Q4 25 | $4.4M | — | ||
| Q3 25 | $4.8M | — | ||
| Q2 25 | $5.1M | — | ||
| Q1 25 | $5.4M | — | ||
| Q4 24 | $11.2M | — | ||
| Q3 24 | $17.3M | — | ||
| Q2 24 | $25.3M | — | ||
| Q1 24 | $25.3M | — |
| Q4 25 | $122.7M | $139.1M | ||
| Q3 25 | $107.7M | $148.8M | ||
| Q2 25 | $94.9M | $-11.9M | ||
| Q1 25 | $82.2M | $18.9M | ||
| Q4 24 | $66.7M | $21.7M | ||
| Q3 24 | $59.7M | $11.2M | ||
| Q2 24 | $40.8M | $39.3M | ||
| Q1 24 | $35.7M | $61.6M |
| Q4 25 | $453.4M | $480.2M | ||
| Q3 25 | $428.6M | $506.9M | ||
| Q2 25 | $393.4M | $372.7M | ||
| Q1 25 | $385.4M | $386.7M | ||
| Q4 24 | $374.9M | $392.3M | ||
| Q3 24 | $347.0M | $363.6M | ||
| Q2 24 | $319.8M | $381.8M | ||
| Q1 24 | $318.3M | $258.7M |
| Q4 25 | 0.04× | — | ||
| Q3 25 | 0.04× | — | ||
| Q2 25 | 0.05× | — | ||
| Q1 25 | 0.07× | — | ||
| Q4 24 | 0.17× | — | ||
| Q3 24 | 0.29× | — | ||
| Q2 24 | 0.62× | — | ||
| Q1 24 | 0.71× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $75.9M | $-25.4M |
| Free Cash FlowOCF − Capex | $73.1M | — |
| FCF MarginFCF / Revenue | 129.5% | — |
| Capex IntensityCapex / Revenue | 5.0% | — |
| Cash ConversionOCF / Net Profit | 5.14× | — |
| TTM Free Cash FlowTrailing 4 quarters | $124.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $75.9M | $-25.4M | ||
| Q3 25 | $25.9M | $-26.6M | ||
| Q2 25 | $9.3M | $-23.3M | ||
| Q1 25 | $17.9M | $-40.4M | ||
| Q4 24 | $57.9M | $-18.8M | ||
| Q3 24 | $21.7M | $-25.2M | ||
| Q2 24 | $7.1M | $-29.1M | ||
| Q1 24 | $6.1M | $-40.7M |
| Q4 25 | $73.1M | — | ||
| Q3 25 | $25.3M | — | ||
| Q2 25 | $8.7M | — | ||
| Q1 25 | $17.0M | — | ||
| Q4 24 | $55.6M | — | ||
| Q3 24 | $21.0M | — | ||
| Q2 24 | $6.6M | — | ||
| Q1 24 | $5.6M | — |
| Q4 25 | 129.5% | — | ||
| Q3 25 | 45.4% | — | ||
| Q2 25 | 16.6% | — | ||
| Q1 25 | 33.7% | — | ||
| Q4 24 | 132.1% | — | ||
| Q3 24 | 51.6% | — | ||
| Q2 24 | 18.1% | — | ||
| Q1 24 | 15.5% | — |
| Q4 25 | 5.0% | — | ||
| Q3 25 | 1.2% | — | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 1.7% | — | ||
| Q4 24 | 5.6% | — | ||
| Q3 24 | 1.7% | — | ||
| Q2 24 | 1.4% | — | ||
| Q1 24 | 1.5% | — |
| Q4 25 | 5.14× | — | ||
| Q3 25 | 2.38× | — | ||
| Q2 25 | 0.82× | — | ||
| Q1 25 | 4.60× | — | ||
| Q4 24 | 10.65× | — | ||
| Q3 24 | 3.12× | — | ||
| Q2 24 | 1.58× | — | ||
| Q1 24 | 4.27× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
